NOVO.B.DK

364

+2.36%↑

GMAB.DK

1,570.5

-0.32%↓

HLUNB.DK

39.8

+1.48%↑

ZEAL.DK

416.8

+2.03%↑

NOVO.B.DK

364

+2.36%↑

GMAB.DK

1,570.5

-0.32%↓

HLUNB.DK

39.8

+1.48%↑

ZEAL.DK

416.8

+2.03%↑

NOVO.B.DK

364

+2.36%↑

GMAB.DK

1,570.5

-0.32%↓

HLUNB.DK

39.8

+1.48%↑

ZEAL.DK

416.8

+2.03%↑

NOVO.B.DK

364

+2.36%↑

GMAB.DK

1,570.5

-0.32%↓

HLUNB.DK

39.8

+1.48%↑

ZEAL.DK

416.8

+2.03%↑

NOVO.B.DK

364

+2.36%↑

GMAB.DK

1,570.5

-0.32%↓

HLUNB.DK

39.8

+1.48%↑

ZEAL.DK

416.8

+2.03%↑

Search

Coloplast A-S (Class B)

Gesloten

613.6 -1.26

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

613.2

Max

621.2

Belangrijke statistieken

By Trading Economics

Inkomsten

-132M

912M

Verkoop

-96M

6.9B

K/W

Sectorgemiddelde

30.059

35.473

EPS

5.45

Dividendrendement

3.59

Winstmarge

13.16

Werknemers

16,741

EBITDA

2.2B

Aanbevelingen

By TipRanks

Aanbevelingen

Neutraal

12 Maanden Prognose

+11.86% upside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

3.59%

2.38%

Volgende Winsten

4 nov 2025

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-20B

137B

Vorige openingsprijs

614.86

Vorige sluitingsprijs

613.6

Coloplast A-S (Class B) Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

22 aug 2025, 23:09 UTC

Acquisities, Fusies, Overnames

Trump Says U.S. Will Take Nearly 10% Equity Stake in Intel -- 4th Update

22 aug 2025, 22:02 UTC

Acquisities, Fusies, Overnames

Agreement Could Also Lead to Deeper Collaboration Between CSX, BNSF

22 aug 2025, 22:02 UTC

Acquisities, Fusies, Overnames

Some Analysts Say Agreement Suggests Lack of Confidence in Merger

22 aug 2025, 22:02 UTC

Acquisities, Fusies, Overnames

CSX, BNSF Intermodal Pact Draws Competing Views on Merger Possibility

22 aug 2025, 22:02 UTC

Acquisities, Fusies, Overnames

CSX, BNSF Pact Sparks Debate on Whether Another Rail Merger Is Approaching -- Analysis

22 aug 2025, 22:02 UTC

Acquisities, Fusies, Overnames

Pact Could Show Regulators That Transcontinental Service Can Come Without Merger

22 aug 2025, 21:23 UTC

Marktinformatie

Moody's Lowers Outlook on Austria to Negative From Stable -- Market Talk

22 aug 2025, 21:18 UTC

Marktinformatie

US Economic Growth Seen Slowing This Year -- Market Talk

22 aug 2025, 21:18 UTC

Acquisities, Fusies, Overnames

U.S. Takes 10% Stake in Intel -- Barrons.com

22 aug 2025, 21:03 UTC

Marktinformatie

Global Forex and Fixed Income Roundup: Market Talk

22 aug 2025, 21:03 UTC

Marktinformatie

Mexican Stocks Close At Record High -- Market Talk

22 aug 2025, 20:58 UTC

Marktinformatie

US General Government Deficit Expected to Rise in 2026, 2027 -- Market Talk

22 aug 2025, 20:57 UTC

Acquisities, Fusies, Overnames

Intel: Government's Investment in Intel Will Be a Passive Ownership, With No Bd Representation or Other Governance or Info Rights >INTC

22 aug 2025, 20:57 UTC

Acquisities, Fusies, Overnames

Intel: Government Also Agrees to Vote With the Company's Bd of Directors on Matters Requiring Shareholder Approval, With Limited Exceptions >INTC

22 aug 2025, 20:57 UTC

Acquisities, Fusies, Overnames

Intel: Government Equity Stake Will Be Funded by Remaining $5.7B in Grants Previously Awarded, But Not Yet Paid, Under U.S. CHIPS and Science Act and $3.2B Awarded as Part of Secure Enclave Program >INTC

22 aug 2025, 20:57 UTC

Acquisities, Fusies, Overnames

Intel: Government Agrees to Purchase 433.3M Primary Shrs of Intel Common Stk at a Price of $20.47 per Shr, Equivalent to a 9.9% Stake in Co >INTC

22 aug 2025, 20:57 UTC

Acquisities, Fusies, Overnames

Intel: U.S. Government to Make $8.9B Investment in Intel Common Stk as Co Builds Upon Its More Than $100B Expansion of Resilient Semiconductor Supply Chain >INTC

22 aug 2025, 20:57 UTC

Acquisities, Fusies, Overnames

Intel: Intel and Trump Admin Reach Historic Agreement to Accelerate Amer Technology and Manufacturing Leadership

22 aug 2025, 20:56 UTC

Winsten

These Stocks Moved the Most Today: Nvidia, Builders FirstSource, Zoom, Intuit, Workday, BJ's, Ubiquiti, and More -- Barrons.com

22 aug 2025, 20:55 UTC

Winsten

These Stocks Are Moving the Most Today: Nvidia, Builders FirstSource, Zoom, Intuit, Workday, BJ's, Ubiquiti, and More -- Barrons.com

22 aug 2025, 20:50 UTC

Marktinformatie
Winsten

Tech, Media & Telecom Roundup: Market Talk

22 aug 2025, 20:50 UTC

Marktinformatie
Acquisities, Fusies, Overnames

Basic Materials Roundup: Market Talk

22 aug 2025, 20:41 UTC

Acquisities, Fusies, Overnames

U.S. Has 10% Stake in Intel, Lutnick Says -- Barrons.com

22 aug 2025, 20:24 UTC

Acquisities, Fusies, Overnames

Trump Says U.S. Will Take Nearly 10% Equity Stake in Intel -- 3rd Update

22 aug 2025, 20:16 UTC

Acquisities, Fusies, Overnames

CSX and Warren Buffett's BNSF Made News. Why Investors Are Disappointed. -- Barrons.com

22 aug 2025, 19:19 UTC

Marktinformatie

Boeing to Restart Talks With Defense Workers' Union Monday -- Market Talk

22 aug 2025, 19:10 UTC

Marktinformatie

Oil Futures Gain as Russia-Ukraine Peace Seems Distant -- Market Talk

22 aug 2025, 19:06 UTC

Marktinformatie

U.S. Natural Gas Extends Losses as Summer Nears an End -- Market Talk

22 aug 2025, 19:03 UTC

Marktinformatie

Lower Borrowing Rates Elusive Even if Fed Cuts -- Market Talk

22 aug 2025, 18:52 UTC

Acquisities, Fusies, Overnames

Trump Says U.S. Will Take Nearly 10% Equity Stake in Intel -- 2nd Update

Peer Vergelijking

Prijswijziging

Coloplast A-S (Class B) Prognose

Koersdoel

By TipRanks

11.86% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 901.38 DKK  11.86%

Hoogste 1,056 DKK

Laagste 720 DKK

Gebaseerd op 8 Wall Street-analisten die 12-maands prijsdoelen bieden voor Coloplast A-S (Class B) - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Neutraal

8 ratings

2

Buy

4

Hold

2

Sell

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.